On July 7, Cathie Wood's Ark Genomic Revolution ETF (ARKG +0.86%) sold over 44,000 shares of BioNTech (BNTX 0.76%), a German ...
The asset management firm’s ETFs bought 100,854 shares of OKLO, valued at about $4.7 million, and 545,453 shares of XE, valued at about $8.7 million.
Cathie Wood boosts her SpaceX stake with a $21.3 million buy, showing conviction as the space giant battles market volatility ...
Ark Invest buys $14M in Circle shares while trimming Robinhood holdings, reflecting ongoing portfolio adjustments across its ...
Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.
On July 6, Cathie Wood was busy with her Ark empire, selling several positions and buying others. One particularly notable ...
The company is likely to play a crucial role in U.S. drone production.
Cathie Wood bought over $2 million of stock in CoreWeave, a Nvidia-backed cloud infrastructure company. Learn more about her reasoning and strategy.
Cathie Wood’s Ark Innovation ETF is down 6.24% year-to-date, while the S&P 500 surged 6.16%. Wood remains optimistic about the market, predicting a rate cut. Wood recently added shares of a tumbling ...